Zestra Reports Positive Results of OTC Feminine Arousal Fluid

Susan Farley
Published Online: Monday, October 1, 2007

A study of nonhormonal, nonprescription feminine arousal fluid from Zestra Laboratories to improve women's sexual experiences showed positive results when compared a placebo oil among the 178 women diagnosed with sexual difficulties who completed the study.

Results were tabulated using the Female Sexual Function Index, a widely used self-assessment questionnaire. A significant benefit of Zestra's fluid was shown over placebo in the desire/satisfaction component. In the arousal component, Zestra's fluid showed a highly significant benefit over placebo. While the FDA does not require clinical trials of nonprescription consumer products, Zestra Laboratories elected to run the trials to assess safety and effectiveness. The product is widely available in drug, supermarket, and discount chain stores.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues